Stefan Herr
Managing Director @ EMBL Ventures
Stefan Herr is a Series A investor at EMBL Ventures focused on Biotechnology and Manufacturing.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Stefan Herr invests in
Stages Stefan Herr invests in
Countries Stefan Herr invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 1 (50%)
- Manufacturing 1 (50%)
- Bioinformatics 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Luxendo
|
Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniquesof widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration. | $8.5M / Series A / Jan 12, 2017 | |
|
Luxendo
|
Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniquesof widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration. | $6.9M / Series A / Oct 14, 2015 |
Co-Investors
About EMBL Ventures
EMBL Ventures is a German venture capital engaged in the financing and development of products and technologies in the healthcare sector. EMBL Ventures manages three Funds with a total of 120m capital on behalf of major European private and institutional investors. We prefer a role as lead or co-lead investor in financing rounds which typicallyrange from 5m to 40m. Our total commitment in a single portfolio company can go as high as 10m. As with our portfolio companies each Partner at EMBL Ventures strives to build long-lasting personal relationships with Investors in our Funds, such as institutionals, high net-worth individuals and family offices. These relationships are based on EMBL Ventures' core values of open and prompt communication coupled with the ambition to generate maximum return.
EMBL Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christoph Antz
Managing Partner
|
|||
|
Jan Adams
Founding Partner
|
|||
|
John Arnold
Manager
|
|||
|
Jorge Galera Garcia Montes
Managing Partner
|
|||
|
Stefan Herr
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Stefan Herr invest in?
Stefan Herr invests primarily in Biotechnology, Manufacturing and Bioinformatics startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Stefan Herr?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Stefan Herr last invest?
The most recent investment recorded for Stefan Herr closed in Jan 2017. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
